Oric Pharmaceuticals Inc stock is traded at $8.49, with a volume of 1,392,668. It is down -9.10% in the last 24 hours and down -32.03% over the past month. ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
Previous Close:
$9.34
Open:
$9.32
24h Volume:
1,392,668
Relative Volume:
0.50
Market Cap:
$880.01M
Revenue:
-
Net Income/Loss:
-$135.21M
P/E Ratio:
-
EPS:
-$1.43
Net Cash Flow:
-$114.35M
1W Performance:
-5.56%
1M Performance:
-32.03%
6M Performance:
-11.29%
1Y Performance:
-31.42%
1-Day Range:
$8.46$9.34
1-Week Range:
$8.46$10.13
52-Week Range:
$7.23$14.68
Oric Pharmaceuticals Inc Stock (ORIC) Company Profile
Name
Oric Pharmaceuticals IncSector
HealthcareIndustry
BiotechnologyPhone
(650) 388-5600Address
240 E. GRAND AVE., SOUTH SAN FRANCISCO, CA, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS